|
WO2021022056A1
|
|
Compositions and methods and uses thereof
|
|
US2019307778A1
|
|
Tetracycline management of egfr inhibitor associated dermatoses
|
|
WO2018234865A1
|
|
Stable topical tetracycline compositions
|
|
CA2978573A1
|
|
Compositions and methods for treating rosacea and acne
|
|
WO2017130058A1
|
|
Hydroalcoholic foam formulations of naftifine
|
|
US2018235984A1
|
|
Tetracycline management of egfr inhibitor associated dermatoses
|
|
US2016158261A1
|
|
Antibiotic Kit and Composition and Uses Thereof
|
|
AU2015224534A1
|
|
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
CA2867419A1
|
|
Use of tetracycline compositions for wound treatment and skin restoration
|
|
US2013225536A1
|
|
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
